Overview of Dr. Drago
Dr. Joshua Drago is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Harvard Medical School and has been in practice 1 year. He is one of 497 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 10 publications and over 500 citings.
Office
300 East 66th Street
Floors 1 - 4
New York, NY 10065
Education & Training
- Massachusetts General HospitalResidency, Internal Medicine, 2015 - 2018
- Harvard Medical SchoolClass of 2015
Certifications & Licensure
- FL State Medical License 2021 - Present
- NJ State Medical License 2020 - 2025
- NY State Medical License 2018 - 2025
- MA State Medical License 2015 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Expanding the use of T-DXd in metastatic HR-positive breast cancer: where are we now?Joshua Drago, Shanu Modi
Nature Reviews. Clinical Oncology. 2025-01-01 - EGFR-directed antibodies promote HER2 ADC internalization and efficacy.Avantika Gupta, Flavia Michelini, Hong Shao, Celine Yeh, Joshua Z Drago
Cell Reports. Medicine. 2024-11-19 - Predictors of response to CDK4/6i retrial after prior CDK4/6i failure in ER+ metastatic breast cancer.Nicholas Mai, Carlos H Dos Anjos, Pedram Razavi, Anton Safonov, Sujata Patil
NPJ Breast Cancer. 2024-10-18
Press Mentions
- ADC Choices Require Discretion in HER2-Negative MBCDecember 28th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: